Works by Banerji, Udai

Results: 38

Treatment-related adverse events of antibody drug-conjugates in clinical trials.

Published in:

Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01720-3

By:

Tan, Harold Nathan;
Morcillo, Marta Ascanio;
Lopez, Juanita;
Minchom, Anna;
Sharp, Adam;
Paschalis, Alec;
Silva-Fortes, Georgina;
Raobaikady, Bindu;
Banerji, Udai

Publication type:

Article

Safety, efficacy and survival of patients with primary malignant brain tumours (PMBT) in phase I (Ph1) trials: the 12-year Royal Marsden experience.

Published in:

Journal of Neuro-Oncology, 2018, v. 139, n. 1, p. 107, doi. 10.1007/s11060-018-2847-z

By:

Coleman, Niamh;
Michalarea, Vasiliki;
Alken, Scheryll;
Rihawi, Karim;
Lopez, Raquel Perez;
Tunariu, Nina;
Petruckevitch, Ann;
Molife, L. R.;
Banerji, Udai;
De Bono, Johann S.;
Welsh, Liam;
Saran, Frank;
Lopez, Juanita

Publication type:

Article

Revisiting the role of molecular targeted therapies in patients with brain metastases.

Published in:

Journal of Neuro-Oncology, 2011, v. 105, n. 3, p. 467, doi. 10.1007/s11060-011-0661-y

By:

Papadatos-Pastos, Dionysis;
Banerji, Udai

Publication type:

Article

Characterisation of the Phosphatidylinositol 3-Kinase Pathway in Non-Small Cell Lung Cancer Cells Isolated from Pleural Effusions.

Published in:

Oncology, 2016, v. 90, n. 5, p. 280, doi. 10.1159/000444928

By:

Puglisi, Martina;
Stewart, adam;
Thavasu, Parames;
Frow, Michael;
Carreira, Suzanne;
Minchom, anna;
Punwani, Ravi;
Bhosle, Jaishree;
Popat, Sanjay;
Ratoff, Jonathan;
de Bono, Johann;
Yap, Timothy anthony;
O''Brien, Mary;
Banerji, Udai

Publication type:

Article

Percentage Change in Plasma Cytokeratin 18 Is Associated with Clinical Outcomes in Patients Receiving Pemetrexed and Carboplatin for the Adenocarcinoma Subtype of NSCLC.

Published in:

Oncology, 2015, v. 89, n. 1, p. 53, doi. 10.1159/000371711

By:

Strimpakos, Alexios S.;
Banerji, Udai;
Thavasu, Parames;
Tsilimagou, Alexandra;
Psyrri, Amanta;
Syrigos, Kostas N.

Publication type:

Article

Outcomes of Patients with Metastatic Melanoma Treated with Molecularly Targeted Agents in Phase I Clinical Trials.

Published in:

Oncology, 2011, v. 81, n. 2, p. 135, doi. 10.1159/000330206

By:

Blanco Codesido, Montserrat;
Tesainer Brunetto, Andre;
Frentzas, Sophia;
Moreno Garcia, Victor;
Papadatos-Pastos, Dionysis;
Pedersen, Joanna Vitfell;
Trani, Leonardo;
Puglisi, Martina;
Molife, L. Rhoda;
Banerji, Udai

Publication type:

Article

Barriers to publishing early phase clinical trials: the oncologists' perspective.

Published in:

Oncologist, 2025, v. 30, n. 4, p. 1, doi. 10.1093/oncolo/oyaf042

By:

Lucassen, Merel J J;
Bergmann, Pedro;
Husson, Olga;
Banerji, Udai;
Basu, Bristi;
Melero, Ignacio;
Calvo, Emiliano;
Cassier, Philippe A;
Drilon, Alexander;
Fong, Peter C;
Garralda, Elena;
Joshua, Anthony M;
Lin, Chia-Chi;
Lopez, Juanita;
Moreno, Victor;
Minchom, Anna;
Plummer, Ruth;
Postel-Vinay, Sophie;
Spreafico, Anna;
Shimizu, Toshio

Publication type:

Article

Hyperglycemia and Phosphatidylinositol 3-Kinase/Protein Kinase B/Mammalian Target of Rapamycin (PI3K/AKT/mTOR) Inhibitors in Phase I Trials: Incidence, Predictive Factors, and Management.

Published in:

Oncologist, 2016, v. 21, n. 7, p. 855, doi. 10.1634/theoncologist.2015-0248

By:

Khan, Khurum H.;
Wong, Mabel;
Rihawi, Karim;
Bodla, Shankar;
Morganstein, Daniel;
Banerji, Udai;
Molife, Lulama R.

Publication type:

Article

Immunoassays for the quantification of ALK and phosphorylated ALK support the evaluation of on-target ALK inhibitors in neuroblastoma.

Published in:

Molecular Oncology, 2017, v. 11, n. 8, p. 996, doi. 10.1002/1878-0261.12069

By:

Tucker, Elizabeth R.;
Tall, Jennifer R.;
Danielson, Laura S.;
Gowan, Sharon;
Jamin, Yann;
Robinson, Simon P.;
Banerji, Udai;
Chesler, Louis

Publication type:

Article

Searching for treatments for non-G12C-KRAS mutant cancers.

Published in:

2021

By:

Guo, Christina;
Banerji, Udai

Publication type:

journal article

Target-based therapeutic matching of phase I trials in patients with metastatic breast cancer in a tertiary referral centre.

Published in:

2018

By:

O’Carrigan, Brent;
Lim, Joline Si Jing;
Jalil, Awais;
Harris, Samuel John;
Papadatos-Pastos, Dionysis;
Banerji, Udai;
Lopez, Juanita;
de Bono, Johann Sebastian;
Yap, Timothy Anthony;
O'Carrigan, Brent

Publication type:

journal article

Insights into significance of combined inhibition of MEK and m-TOR signalling output in KRAS mutant non-small-cell lung cancer.

Published in:

2016

By:

Broutin, Sophie;
Stewart, Adam;
Thavasu, Parames;
Paci, Angelo;
Bidart, Jean-Michel;
Banerji, Udai

Publication type:

journal article

Antibody-drug conjugates--an emerging class of cancer treatment.

Published in:

2016

By:

Diamantis, Nikolaos;
Banerji, Udai

Publication type:

journal article

Effects of HSP90 inhibitor 17-allylamino-17 -demethoxygeldanamycin (17-AAG) on NEU/HER2 overexpressing mammary tumours in MMTV-NEU-NT mice monitored by Magnetic Resonance Spectroscopy.

Published in:

BMC Research Notes, 2012, v. 5, n. 1, p. 250, doi. 10.1186/1756-0500-5-250

By:

Rodrigues, Loretta M;
Chung, Yuen-Li;
Al Saffar, Nada M;
Sharp, Swee Y;
Jackson, Laura E;
Banerji, Udai;
Stubbs, Marion;
Leach, Martin O;
Griffiths, John R;
Workman, Paul

Publication type:

Article

Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models.

Published in:

2018

By:

Banerji, Udai;
Sain, Nivedita;
Sharp, Swee Y.;
Valenti, Melanie;
Asad, Yasmin;
Ruddle, Ruth;
Raynaud, Florence;
Walton, Michael;
Eccles, Suzanne A.;
Judson, Ian;
Jackman, Ann L.;
Workman, Paul

Publication type:

Correction Notice

Correction to: An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models.

Published in:

2018

By:

Banerji, Udai;
Sain, Nivedita;
Sharp, Swee Y;
Valenti, Melanie;
Asad, Yasmin;
Ruddle, Ruth;
Raynaud, Florence;
Walton, Michael;
Eccles, Suzanne A;
Judson, Ian;
Jackman, Ann L;
Workman, Paul

Publication type:

corrected article

A Phase 1, open-label, multicentre study to compare the capsule and tablet formulations of AZD5363 and explore the effect of food on the pharmacokinetic exposure, safety and tolerability of AZD5363 in patients with advanced solid malignancies: OAK.

Published in:

2018

By:

Dean, Emma;
Banerji, Udai;
Schellens, Jan H. M.;
Krebs, Matthew G.;
Jimenez, Begona;
van Brummelen, Emilie;
Bailey, Chris;
Casson, Ed;
Cripps, Diana;
Cullberg, Marie;
Evans, Stephen;
Foxley, Andrew;
Lindemann, Justin;
Rugman, Paul;
Taylor, Nigel;
Turner, Guy;
Yates, James;
Lawrence, Peter

Publication type:

journal article

An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 769, doi. 10.1007/s00280-007-0662-x

By:

Banerji, Udai;
Sain, Nivedita;
Sharp, Swee Y.;
Valenti, Melanie;
Asad, Yasmin;
Ruddle, Ruth;
Raynaud, Florence;
Walton, Michael;
Eccles, Suzanne A.;
Judson, Ian;
Jackman, Ann L.;
Workman, Paul

Publication type:

Article

Preliminary evidence of antitumour activity of Ipatasertib (Ipat) and Atezolizumab (ATZ) in glioblastoma patients (pts) with PTEN loss from the Phase 1 Ice-CAP trial (NCT03673787).

Published in:

2021

By:

Tiu, Crescens;
Welsh, Liam;
Jones, Timothy;
Zachariou, Anna;
Prout, Toby;
Turner, Alison;
Daly, Rob;
Tunariu, Nina;
Riisnaes, Ruth;
Gurel, Bora;
Crespo, Mateus;
Carreira, Suzanne;
Vivanco, Igor;
Jenkins, Ben;
Yap, Christina;
Minchom, Anna;
Banerji, Udai;
deBono, Johann;
Lopez, Juanita

Publication type:

Abstract

A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments.

Published in:

PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0186106

By:

Minchom, Anna;
Thavasu, Parames;
Ahmad, Zai;
Stewart, Adam;
Georgiou, Alexandros;
O’Brien, Mary E. R.;
Popat, Sanjay;
Bhosle, Jaishree;
Yap, Timothy A.;
de Bono, Johann;
Banerji, Udai

Publication type:

Article

Metabolomic changes of the multi (-AGC-) kinase inhibitor AT13148 in cells, mice and patients are associated with NOS regulation.

Published in:

Metabolomics, 2020, v. 16, n. 4, p. 1, doi. 10.1007/s11306-020-01676-0

By:

Pal, Akos;
Asad, Yasmin;
Ruddle, Ruth;
Henley, Alan T.;
Swales, Karen;
Decordova, Shaun;
Eccles, Suzanne A.;
Collins, Ian;
Garrett, Michelle D.;
De Bono, Johann;
Banerji, Udai;
Raynaud, Florence I.

Publication type:

Article

The kinase polypharmacology landscape of clinical PARP inhibitors.

Published in:

Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-59074-4

By:

Antolin, Albert A.;
Ameratunga, Malaka;
Banerji, Udai;
Clarke, Paul A.;
Workman, Paul;
Al-Lazikani, Bissan

Publication type:

Article

Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39679-9

By:

Spicer, James;
Basu, Bristi;
Montes, Ana;
Banerji, Udai;
Kristeleit, Rebecca;
Miller, Rowan;
Veal, Gareth J.;
Corrigan, Christopher J.;
Till, Stephen J.;
Figini, Mariangela;
Canevari, Silvana;
Barton, Claire;
Jones, Paul;
Mellor, Sarah;
Carroll, Simon;
Selkirk, Chris;
Nintos, George;
Kwatra, Vineet;
Funingana, Ionut-Gabriel;
Doherty, Gary

Publication type:

Article

A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAF<sup>V600</sup> wild-type colorectal cancer.

Published in:

Cellular Oncology (2211-3428), 2021, v. 44, n. 5, p. 1197, doi. 10.1007/s13402-021-00628-7

By:

Georgiou, Alexandros;
Stewart, Adam;
Vlachogiannis, Georgios;
Pickard, Lisa;
Valeri, Nicola;
Cunningham, David;
Whittaker, Steven R.;
Banerji, Udai

Publication type:

Article

A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma.

Published in:

Investigational New Drugs, 2012, v. 30, n. 1, p. 341, doi. 10.1007/s10637-010-9493-4

By:

Pacey, Simon;
Gore, Martin;
Chao, David;
Banerji, Udai;
Larkin, James;
Sarker, Sarah;
Owen, Karen;
Asad, Yasmin;
Raynaud, Florence;
Walton, Mike;
Judson, Ian;
Workman, Paul;
Eisen, Tim

Publication type:

Article

A study of motivations and expectations of patients seen in phase 1 oncology clinics.

Published in:

2016

By:

Dolly, Saoirse O.;
Kalaitzaki, Eleftheria;
Puglisi, Martina;
Stimpson, Sarah;
Hanwell, Janet;
Fandos, Sonia Serrano;
Stapleton, Sarah;
Ansari, Thushara;
Peckitt, Clare;
Kaye, Stan;
Lopez, Juanita;
Yap, Timothy A.;
van der Graaf, Winette;
de Bono, Johann;
Banerji, Udai

Publication type:

journal article

A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer.

Published in:

British Journal of Cancer, 2023, v. 129, n. 1, p. 38, doi. 10.1038/s41416-023-02279-x

By:

Kristeleit, Rebecca;
Plummer, Ruth;
Jones, Robert;
Carter, Louise;
Blagden, Sarah;
Sarker, Debashis;
Arkenau, Tobias;
Evans, Thomas R. Jeffry;
Danson, Sarah;
Symeonides, Stefan N.;
Veal, Gareth J.;
Klencke, Barbara J.;
Kowalski, Mark M.;
Banerji, Udai

Publication type:

Article

Correction to: Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease.

Published in:

2021

By:

Collins, Dearbhaile Catherine;
Sundar, Raghav;
Constantinidou, Anastasia;
Dolling, David;
Yap, Timothy Anthony;
Popat, Sanjay;
O'Brien, Mary E.;
Banerji, Udai;
de Bono, Johann Sebastian;
Lopez, Juanita Suzanne;
Tunariu, Nina;
Minchom, Anna

Publication type:

corrected article

Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease.

Published in:

2020

By:

Collins, Dearbhaile Catherine;
Sundar, Raghav;
Constantidinou, Anastasia;
Dolling, David;
Yap, Timothy Anthony;
Popat, Sanjay;
O'Brien, Mary E.;
Banerji, Udai;
de Bono, Johann Sebastian;
Lopez, Juanita Suzanne;
Tunariu, Nina;
Minchom, Anna;
Constantinidou, Anastasia

Publication type:

journal article

Phase I trials in patients with relapsed, advanced upper gastrointestinal carcinomas: experience in a specialist unit.

Published in:

Gastric Cancer, 2014, v. 17, n. 4, p. 621, doi. 10.1007/s10120-013-0328-9

By:

Khan, Khurum;
Ang, Joo;
Starling, Naureen;
Sclafani, Francesco;
Shah, Krunal;
Judson, Ian;
Molife, L.;
Banerji, Udai;
Bono, Johann;
Cunningham, David;
Kaye, Stan

Publication type:

Article

Two Distinct Ways to Target KRAS-Mutant Tumors Hint at Efficacy.

Published in:

Journal of Oncology Navigation & Survivorship, 2020, v. 11, n. 8, p. 285

By:

Banerji, Udai

Publication type:

Article

Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone.

Published in:

Oncogene, 2000, v. 19, n. 36, p. 4125, doi. 10.1038/sj.onc.1203753

By:

Clarke, Paul A;
Hostein, Isabelle;
Banerji, Udai;
Stefano, Francesca Di;
Maloney, Alison;
Walton, Mike;
Judson, Ian;
Workman, Paul

Publication type:

Article

Exploiting evolutionary steering to induce collateral drug sensitivity in cancer.

Published in:

Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15596-z

By:

Acar, Ahmet;
Nichol, Daniel;
Fernandez-Mateos, Javier;
Cresswell, George D.;
Barozzi, Iros;
Hong, Sung Pil;
Trahearn, Nicholas;
Spiteri, Inmaculada;
Stubbs, Mark;
Burke, Rosemary;
Stewart, Adam;
Caravagna, Giulio;
Werner, Benjamin;
Vlachogiannis, Georgios;
Maley, Carlo C.;
Magnani, Luca;
Valeri, Nicola;
Banerji, Udai;
Sottoriva, Andrea

Publication type:

Article

Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers.

Published in:

PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0047020

By:

Perkins, Geraldine;
Yap, Timothy A.;
Pope, Lorna;
Cassidy, Amy M.;
Dukes, Juliet P.;
Riisnaes, Ruth;
Massard, Christophe;
Cassier, Philippe A.;
Miranda, Susana;
Clark, Jeremy;
Denholm, Katie A.;
Thway, Khin;
De Castro, David Gonzalez;
Attard, Gerhardt;
Molife, L. Rhoda;
Kaye, Stan B.;
Banerji, Udai;
de Bono, Johann S.

Publication type:

Article

A single‐centre study evaluating a geriatric screening tool in oncology phase I trial patients.

Published in:

Cancer Reports, 2024, v. 7, n. 6, p. 1, doi. 10.1002/cnr2.2083

By:

Van Zyl, Mary;
Barell, Anne;
Cooley, Bridget;
Hanwell, Janet;
Parlak, Josie;
Banerji, Udai;
De Bono, Johann;
Sharp, Adam;
Lopez, Juanita;
Battisti, Nicolo Matteo Luca;
Minchom, Anna

Publication type:

Article

Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models.

Published in:

2003

By:

Chung, Yuen-Li;
Troy, Helen;
Banerji, Udai;
Jackson, Laura E;
Walton, Mike I;
Stubbs, Marion;
Griffiths, John R;
Judson, Ian R;
Leach, Martin O;
Workman, Paul;
Ronen, Sabrina M

Publication type:

journal article

Magnetic Resonance Spectroscopic Pharmacodynamic Markers of the Heat Shock Protein 90 Inhibitor 17-Allylamino,17-Demethoxygeldanamycin (17AAG) in Human Color Cancer Models.

Published in:

JNCI: Journal of the National Cancer Institute, 2003, v. 95, n. 21, p. 1624, doi. 10.1093/jnci/djg084

By:

Yuen-Li Chung, Aaron;
Troy, Helen;
Banerji, Udai;
Jackson, Laura E.;
Walton, Mike I.;
Stubbs, Marion;
Griffiths, John R.;
Judson, Ian R.;
Leach, Martin O.;
Workman, Paul;
Ronen, Sabrina M.

Publication type:

Article

Combinatorial drug therapy for cancer in the post-genomic era.

Published in:

Nature Biotechnology, 2012, v. 30, n. 7, p. 679, doi. 10.1038/nbt.2284

By:

Al-Lazikani, Bissan;
Banerji, Udai;
Workman, Paul

Publication type:

Article